CFO transitions at Translate, Spero, Ziopharm, Precision, CASI, Tessa, Kiniksa and Aquestive; plus updates from 3T, Novavax, Alnylam and more
mRNA company Translate Bio Inc. (NASDAQ:TBIO) announced John Schroer will step down as CFO at year-end. VP and corporate controller Robert Prentiss will serve as principal accounting officer on an interim basis.
Antibiotics developer Spero Therapeutics Inc. (NASDAQ:SPRO) appointed Satyavrat “Sath” Shukla as CFO, effective Jan. 4. Shukla